We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Tissue-Imaging Technology Enables Real-Time Diagnostics

By LabMedica International staff writers
Posted on 04 Jul 2018
Print article
Image: A tissue-imaging microscope has been developed that can image living tissue in real time and molecular detail, allowing them to monitor tumors and their environments as cancer progresses (Photo courtesy of Professor Stephen Boppart).
Image: A tissue-imaging microscope has been developed that can image living tissue in real time and molecular detail, allowing them to monitor tumors and their environments as cancer progresses (Photo courtesy of Professor Stephen Boppart).
A new microscope system can image living tissue in real time and in molecular detail, without any chemicals or dyes. The system is called simultaneous label-free autofluorescence multi-harmonic microscopy (SLAM).

The system uses precisely tailored pulses of light to simultaneously image with multiple wavelengths. This enables scientists to study concurrent processes within cells and tissue, and could give those studying cancer a new tool for tracking tumor progression and physicians new technology for tissue pathology and diagnostics.

Scientists at the University of Illinois at Urbana-Champaign, Urbana, IL, USA) designed an optical imaging platform that performs simultaneous label-free autofluorescence-multiharmonic (SLAM) microscopy, featuring fast epi-detection of nicotinamide adenine dinucleotide (NADH) from three-photon autofluorescence (3PAF) and simultaneous, and efficient acquisition of autofluorescence (FAD) from two-photon autofluorescence (2PAF), combined with non-centrosymmetric structures from second-harmonic generation (SHG) and interfacial features from third-harmonic generation (THG).

The team saw that the cells near the mammary tumors in rats had differences in metabolism and morphology, indicating that the cells had been recruited by the cancer. In addition, they observed surrounding tissues creating infrastructure to support the tumor, such as collagen and blood vessels. They also saw communication between the tumor cells and the surrounding cells in the form of vesicles, tiny transport packages released by cells and absorbed by other cells. The authors concluded that they had demonstrated the versatility and efficiency of SLAM microscopy for tracking cellular events in vivo, and are a major enabling advance in label-free intravital microscopy (IVM).

Stephen A. Boppart, MD, PhD, a professor and head of the Biophotonics Imaging Laboratory, and senior author of the study, said, “With advances in microscopy techniques such as ours, we hope to change the way we detect, visualize and monitor diseases that will lead to better diagnosis, treatments and outcomes.” The study was published on May 29, 2018, in the journal Nature Communications.

Related Links:
University of Illinois at Urbana-Champaign

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC
New
Amoebiasis Test
ELI.H.A Amoeba

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.